Immunovant

We are aware of fraudulent emails, texts, and job postings claiming to be from Immunovant. These messages often attempt to deceive individuals into believing they have been selected for an interview or job that is not officially posted by our company. Please be aware that: • All legitimate job applications should be submitted through our careers site at immunovant.com/join-us/ • Our HR team does not conduct interviews through Telegram, Google Hangouts, or Microsoft Teams. The majority of our interviews are conducted via Zoom.   •We never ask for bank information or money for IT equipment as part of our recruitment process. To protect yourself: • Always verify job postings on our official careers page.   • Never share personal information unless you’re confident the request is legitimate.   • Contact us directly at careers@immunovant.com if you receive suspicious communication or have concerns. Thank you for helping us maintain a safe and secure job application process.  

Development updates and financial results for the fiscal quarter ended September 30, 2024 are now available: https://lnkd.in/eF3-RRXP #PressRelease #batoclimab #GravesDisease #FcRn #RheumatoidArthritis #CIDP #ThyroidEyeDisease #MyastheniaGravis #AntithyroidDrugs #thyroid #hyperthyroidism #InvisibleDisability #AutoImmuneDisease #autoimmune #PatientFirst #healthcare #IMVT 

Larissa Felt, Senior Director, Clinical Operations at Immunovant, recently attended the American Thyroid Association, Inc. (ATA) Annual Meeting. She shared that the event was, “an exciting opportunity to understand the perspectives of both physicians and those living with Graves’ disease.” To learn more about Immunovant’s Graves’ disease program, visit: immunovant.com #2024ATA #GravesDisease #thyroid #hyperthyroidism #InvisibleDisability #AutoImmuneDisease #autoimmune #PatientFirst #healthcare

Today, we announced that data from the Phase 2a trial of #batoclimab in #GravesDisease will be the subject of an oral presentation of a late-breaking abstract accepted for the 2024 American Thyroid Association, Inc. (ATA) Annual Meeting. To read the full #PressRelease, visit: https://lnkd.in/e4DKqhK9 #thyroid #hyperthyroidism #InvisibleDisability #AutoImmuneDisease #autoimmune #PatientFirst #healthcare

"It’s important to understand what lab values are and how to read them,” advises Andrea, who was diagnosed with #GravesDisease in 2016. As an advocate for people living with Graves’ disease, Andrea shares this tip in her conversations with others. She believes that patients should prepare themselves with as much knowledge as possible. To watch more of Andrea’s story as well as others living with #AutoimmuneDiseases in honor of #InvisibleDisabilitiesWeek, visit: https://lnkd.in/e7HwrJUV #endocrinology #thyroid #hyperthyroidism #InvisibleDisability #AutoImmuneDisease #autoimmune #PatientFirst #healthcare

#MyastheniaGravis (MG) is a rare and chronic autoimmune disease with most people requiring long-term treatment. A recent study highlights increased rates of hospitalization and ICU admissions for people with MG compared to the general population. Our company was built around the idea that therapies for people with autoimmune diseases should be tailored to their complex and variable needs. Learn more about our efforts to develop a potential new treatment for MG at: https://lnkd.in/etriCUUd #MGStrong #AutoImmuneDisease #RareDisease #PatientFirst #healthcare

"The first step in dealing with the chronic fatigue associated with myasthenia gravis (MG) is learning not to punish yourself for it. I often find myself feeling guilty, frustrated, or resentful because I know what my mind is capable of or what my heart desires, but my body doesn't allow me to fulfill that potential or those needs. Whether I must cancel plans with friends and family or reschedule a meeting at work, I have to accept that my body is doing the best it can and that is enough. Surround yourself with people who understand that." - Meridith O’Connor, MSW Assistant VP of Patient Engagement, Advocacy & Policy Myasthenia Gravis Foundation of America, Inc. At Immunovant, we’re pursuing a patient-focused development approach with the goal of enabling normal lives for people with #MyastheniaGravis and other autoimmune diseases. Learn more here: https://lnkd.in/etriCUUd #MGreality #MGStrong #AutoImmuneDisease #Autoimmune #RareDisease #PatientFirst #healthcare

"My mom is there for my highs and lows. I’m a shy kid, but she teaches me independence and the importance of getting out there. And that’s my ‘why’ for being at the MG Walk -- to show my support during her highs and lows while living with myasthenia gravis (MG)." - Curtis, pictured with his mom, Latasha, while attending Myasthenia Gravis Foundation of America, Inc.'s recent #MGwalk in NYC. At Immunovant, we’re committed to helping address the complex and variable needs of people living with MG. Learn more about our efforts to develop a potential new treatment for MG at: https://lnkd.in/etriCUUd #WhyWeWalk #MyastheniaGravis #AutoImmuneDisease #neurology #Autoimmune #RareDisease #PatientFirst #healthcare

In people living with #MyastheniaGravis (MG), the body’s immune system attacks the connections between nerves and muscles, causing weakness and other symptoms. A recent study showed that fatigue is the most commonly reported symptom of MG, followed by muscle weakness, most often affecting the eyelids, arms or legs. At Immunovant, we’re committed to helping to address the complex and variable needs of people living with MG. Learn more about our efforts to develop a potential new treatment for MG at: https://lnkd.in/etriCUUd #MGStrong #AutoImmuneDisease #RareDisease #PatientFirst #healthcare

"Once, I had to be air lifted and put on life support because of my myasthenia gravis (MG). Until that point, I pretended my symptoms weren’t so bad. I realized I needed to be open with those around me, but that took practice. It took years for me to get comfortable being open with my doctors about the severity of my myasthenia gravis symptoms." - Katie Coffman, living with myasthenia gravis Support Group Leader At Immunovant, we’re focused on developing therapies that may potentially address the complex and variable needs of people with autoimmune diseases like myasthenia gravis. Learn more about our development program in MG: https://lnkd.in/etriCUUd #MyastheniaGravis #MGstrong #neurology #InvisibleDisability #AutoImmuneDisease #autoimmune #PatientFirst #healthcare